spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  AnorMED 

 HSMN NewsFeed - 8 Mar 2016
Accera Appoints Ernest Wong, Ph.D., as Head of Corporate Development
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 14 Dec 2015
X4 Pharmaceuticals Unveils Development Strategy for CXCR4 Inhibitor Pipeline in Cancer Supported by $37.5 million Series A Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 6 Jan 2014
Tekmira Announces Strategic Reorganization to Strengthen Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Sep 2010
Tekmira Pharmaceuticals Strengthens Management Team With Addition of Paul Brennan as Senior Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Nov 2009
Inimex Announces Appointment of New CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Dec 2008
FDA Approves Genzyme's Mozobil
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Sep 2008
Tekmira Pharmaceuticals Expands Executive Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2008
Callisto Pharmaceuticals Amends and Restates Atiprimod License Agreement with Genzyme
Biopharmaceuticals Licensing
 HSMN NewsFeed - 19 Jul 2007
Genzyme Announces Phase 3 Trial of Mozobil in non-Hodgkin's Lymphoma Meets Primary Endpoint
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Jun 2007
Callisto Pharmaceuticals Files Suit Against Former Executive Vice President for Breach of Employment Agreement, Fraud, Conversion and Related Claims
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Dec 2006
Dr. Geoffrey Henson to Join Callisto Pharmaceuticals
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Dec 2006
Callisto Pharmaceuticals Files Suit Against Tapestry Pharmaceuticals for Breach of Confidential Disclosure Agreement
Biopharmaceuticals Litigation
 HSMN NewsFeed - 7 Nov 2006
Genzyme Completes Tender Offer for Outstanding Shares of AnorMED
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Nov 2006
Callisto Pharmaceuticals Initiates Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Nov 2006
Genzyme and AnorMED Announce Completion of Hart-Scott-Rodino Review
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Oct 2006
Genzyme Extends Deadline for Tender Offer to Acquire AnorMED Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Oct 2006
Koronis Pharmaceuticals Appoints Stephen Becker, M.D., Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Oct 2006
Genzyme and AnorMED Reach Agreement on Acquisition
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Oct 2006
Millennium Issues Statement Regarding AnorMED Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Oct 2006
AnorMED has determined Genzyme's offer is a 'superior proposal'
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Oct 2006
Genzyme Announces Proposal to Increase Its Offer to Acquire AnorMED to $13.50 Per Share in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Oct 2006
Genzyme Extends Deadline for Tender Offer to Acquire AnorMED Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Sep 2006
Millennium Agrees to Acquire AnorMED, Adding Phase III Oncology Product with Planned Near Term Launch Date
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Sep 2006
Callisto Pharmaceuticals Granted Orphan Drug Designation for Atiprimod to Treat Carcinoid Tumors
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 25 Sep 2006
Approval of FOSRENOL in the United Kingdom triggers U.S.$3 million payment to AnorMED
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Sep 2006
AnorMED amends license agreement for cancer drug
Biopharmaceuticals Licensing
 HSMN NewsFeed - 19 Sep 2006
Poniard Pharmaceuticals Expands Picoplatin Agreement to Include Exclusive Worldwide Rights and Improved Financial Terms and Conditions
Biopharmaceuticals Licensing
 HSMN NewsFeed - 10 Jul 2006
AnorMED completes enrollment in Phase III trial for MOZOBIL in stem cell transplant in multiple myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 May 2006
AnorMED President and CEO Michael Abrams steps down
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 36

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 36 additional stories matching:
AnorMED
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.